It is known that serum heparin cofactor II-thrombin complex (HCII-T) levels are markedly elevated in untreated MPS I, II, and VI patients, correlating with disease severity and treatment response, making it a valuable biomarker for assessment and monitoring [76, 77]. This evidence concerns the gene SERPIND1 and Scheie syndrome.